Duke-NUS - Cancer and Stem Cell Biology

Overview

The Programme in Cancer and Stem Cell Biology (CSCB) is one of five founding Signature Research Programmes of the Duke-NUS Medical School. CSCB has a broad scope of research. Our faculty engage in hypothesis-driven basic science and disease-oriented investigation, as well as active drug discovery and innovative clinical trials. We are committed to translation of key findings, and our faculty have moved basic science discoveries from bench to bedside, with clinical trials in multiple cancers driven by discoveries made by CSCB scientists.

Our Vision

Pioneering cancer care through research and education. 

Our Mission

Conducting world-class research and training in cancer and stem cell biology, through leveraging resources and collaborations in Duke-NUS, Singapore, Duke USA, and throughout the world.

Director's Message

Welcome to the website of The Programme in Cancer and Stem Cell Biology (CSCB).

CSCB is one of five founding Signature Research Programmes of the Duke-NUS Medical School. Our Programme recruited its first faculty members in 2006, and we moved to the purpose-built Khoo Teck Puat (KTP) building in 2009. CSCB is an essential component of Duke-NUS. We engage in world-class research and training for scientists on both the PhD and MD/PhD tracks. 

The CSCB core faculty have research labs in KTP. The impact of CSCB is greatly enhanced by our diverse collaborative networks. We have a close relationship with researchers at the National Cancer Centre Singapore and the Department of Haematology on the Outram Campus of SingHealth. Our faculty work closely with researchers and clinicians throughout Singapore, most notably with the Cancer Science Institute at the National University Hospital and A*STaR laboratories at Biopolis. Several faculty have major ongoing projects with the Experimental Therapeutics Centre, whose mission is to develop new drugs.

CSCB has a broad scope of research. Our faculty engage in hypothesis-driven basic science and disease-oriented investigation, as well as active drug discovery and innovative clinical trials. We are committed to translation of key findings, and our faculty have moved basic science discoveries from bench to bedside, with clinical trials in gastric cancer, lung cancer and leukemia driven by discoveries made by CSCB scientists.

We welcome your interest, and we encourage you to learn more about the research and training opportunities offered by our program.

 

David M. Virshup

Professor and Director

Events

Research
02 Dec 2024
Noon Seminar: Dr. James Murphy - “Shining a light on dark and gloomy kinases”
Research
14 Oct 2024
Noon Seminar: Dr. Andreas Strasser - “How does mutant p53 drive the development and expansion of cancer?”
Research
04 Jul 2024
Noon Seminar: Dr. Louise Cheng - “Understanding plasticity during de-dedifferentiation”
Research
03 Jun 2024
Noon Seminar : Dr. Fan BAI - "Somatic mutagenesis in morphologically normal human tissues"
Research
09 May 2024
Noon Seminar: Dr. Kristijan Ramadan - “Chromatin-Associated Degradation (CHROMAD) in genome stability and cancer therapy”
Research
29 Apr 2024
Noon Seminar: Dr. Tatsuhiro Shibata - “Driver gene landscape in gastric cancer”

Browser not supported

Modern websites need modern browsers

To enjoy the full experience, please upgrade your browser

Try this browser